Metaphedrine
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Designer drug
Pharmaceutical compound
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H17N |
Molar mass | 163.264 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021.[1]
See also
- 3-Chloromethamphetamine
- 3-Methoxymethamphetamine
- 3-Methylamphetamine
- 3-Methylmethcathinone
- 3-Me-PVP
- 4-Methylmethamphetamine
- Fenfluramine
- 3,4-Dimethylamphetamine
References
- ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 2024-11-02). ISBN 978-92-9497-737-3.
{{cite book}}
: CS1 maint: DOI inactive as of November 2024 (link)
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- CS1 maint: DOI inactive as of November 2024
- Articles with short description
- Short description is different from Wikidata
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- All stub articles